Publications by authors named "Maria Antonia Ruiz-Cobo"
Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study.
Reyes Jiménez-Bárcenas Gloria García-Donas-Gabaldón Rosa María Campos-Álvarez María Carmen Fernández-Sánchez de Mora Josefa Luis-Navarro María Antonia Ruiz-Cobo
Br J Haematol
May 2024
Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase inhibitor, has been approved as a second-line treatment for ITP. Real-world data on fostamatinib are lacking.
View Article and Find Full Text PDF